GlassScriptPhysician profile
Johnny William Swiger
NPI 1700855962
$2,143.90
in general payments reported to CMS, 2019-2025
17 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $55.65 · 2021: $299 · 2022: $312 · 2023: $88.58 · 2024: $232 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $794 · Food and Beverage: $384 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $793.96 |
| Food and Beverage | $384.25 |
| Education | $147.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $941.00 | 2025 | |
| Abbvie INC. | $445.33 | 2019-2022 | |
| Astellas Pharma US INC | $318.08 | 2019-2025 | Veozah, Myrbetriq |
| Ethicon US, LLC | $103.64 | 2021 | |
| Roche Diagnostics Corporation | $54.30 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $53.03 | 2024-2025 | Myfembree |
| Millicent US INC | $49.54 | 2019-2024 | Femring, Intrarosa |
| Coloplast Corp | $23.17 | 2022 | |
| Therapeuticsmd, INC. | $21.27 | 2022 | |
| Vertical Pharmaceuticals, LLC | $19.42 | 2019 | |
| Scynexis, INC. | $19.32 | 2022 | |
| Duchesnay USA Incorporated | $18.54 | 2020 | |
| Ascend Therapeutics US, LLC | $18.18 | 2021 | |
| Exeltis, USA INC. | $17.44 | 2019 | |
| Merck Sharp & Dohme LLC | $14.65 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $13.81 | 2024 | |
| Coopersurgical, INC. | $13.18 | 2023 | Summit Doppler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Swiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.